Literature DB >> 15941431

Thyroid autoimmunity in children and adolescents with alopecia areata.

Alexander Kurtev1, Emil Iliev.   

Abstract

BACKGROUND: Autoimmune thyroiditis (AT) is often associated with alopecia areata (AA) in children and adolescents.
METHODS: Forty-six children (23 girls and 23 boys), with a mean age of 9.9 +/- 3.38 years (2.24-17.5 years), were included in a study to assess thyroid function and thyroid autoantibody formation in AA. The size and function of the thyroid gland [triiodothyronine (T3), thyroxine (T4), thyroid-stimulating hormone (TSH), and thyrotropin releasing hormone (TRH) test; fluoroimmunologic assay (FIA), Delfia], antithyroglobulin (TAT) and antimicrosomal (MAT) antibodies (microhemagglutination method), thyroid gland ultrasound, and indices of cellular and humoral immunity were assessed.
RESULTS: Thyromegaly was found in 29 children (63%). Increased basal TSH levels were present in six of the 29 (13.3%) and hypothyroid-type stimulated secretion (TRH test) in two (out of 12). TAT was increased in 17 (39.5%) and MAT in 14 (33.3%) children with AA. Thyroid ultrasound examination was suggestive of AT in 13 (34.2%) and typical of AT in five (13.2%) children.
CONCLUSIONS: We diagnosed AT in 22 of 46 children with AA (47.8%). The immune studies revealed increased activated T lymphocytes. We recommend that thyroid gland size and function and antibody formation be examined at the diagnosis of AA and twice a year thereafter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941431     DOI: 10.1111/j.1365-4632.2005.01971.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

2.  A retrospective study of thyroid structural abnormalities in alopecia patients.

Authors:  Kristen Lo Sicco; Sean McGuire; Joseph C English
Journal:  Dermatoendocrinol       Date:  2011-10-01

3.  A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.

Authors:  Daniela Mikhaylov; Jacob W Glickman; Ester Del Duca; John Nia; Peter Hashim; Giselle K Singer; Alba L Posligua; Aleksandra G Florek; Erin Ibler; Erika L Hagstrom; Yeriel Estrada; Stephanie M Rangel; Maria Colavincenzo; Amy S Paller; Emma Guttman-Yassky
Journal:  Arch Dermatol Res       Date:  2022-03-01       Impact factor: 3.017

Review 4.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

5.  Comorbidities of Alopecia Areata in Finland between 1987 and 2016.

Authors:  Idamaria Laitinen; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja
Journal:  Acta Derm Venereol       Date:  2020-02-25       Impact factor: 3.875

6.  The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.

Authors:  Gulcan Saylam Kurtipek; Fatma Gökşin Cihan; Şule Erayman Demirbaş; Arzu Ataseven
Journal:  Biomed Res Int       Date:  2015-08-18       Impact factor: 3.411

Review 7.  Immunology of alopecia areata.

Authors:  Marta Żeberkiewicz; Lidia Rudnicka; Jacek Malejczyk
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

8.  Thyroid disorders associated with alopecia areata in egyptian patients.

Authors:  Ola A Bakry; Mohamed A Basha; Maather K El Shafiee; Wafaa A Shehata
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.